Literature DB >> 17464863

Helicobacter pylori-associated chronic idiopathic thrombocytopenic purpura and low molecular weight H. pylori proteins.

Norihito Morimoto1, Hiroaki Takeuchi, Toru Takahashi, Tadashi Ueta, Yukio Tanizawa, Yoshitaka Kumon, Michiya Kobayashi, Tetsuro Sugiura.   

Abstract

We examined the association between Helicobacter pylori infection and chronic idiopathic thrombocytopenic purpura (cITP) to clarify the development of H. pylori-associated cITP. cITP patients were classified into 3 different groups: Hp-negative (HP-N); Hp-positive, completely or partially responsive to treatment (CR); and Hp-positive and unresponsive to treatment (NR). Reactivity of antibodies to H. pylori before and after eradication was examined by immunoblotting. We used immunoblotting with immunoprecipitation to establish whether platelets form complexes with H. pylori proteins and if these complexes react with patients' sera. CR group showed large (>50 kDa) and low molecular weight protein bands, especially of 36, 27 and 17-kDa. These low molecular weight bands were detected significantly more in the CR group compared to other groups. When healthy human platelets were incubated with H. pylori lysate, they aggregated with the lysate, indicating that complexes were formed between the platelets and the lysate. The complexes immunoprecipitated with anti-human thrombocyte antibodies, and showed a 17 kDa band in the CR, but not in other groups. At least 3 low molecular weight proteins of H. pylori were involved in H. pylori-associated cITP. Immunocomplexes consisting of platelets, low molecular weight proteins of H. pylori and anti-H. pylori antibodies may represent an extra mechanism in development of H. pylori- associated cITP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464863     DOI: 10.1080/00365540601105723

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review.

Authors:  Donald M Arnold; Ashley Bernotas; Ishac Nazi; Roberto Stasi; Masataka Kuwana; Yang Liu; John G Kelton; Mark A Crowther
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

2.  Helicobacter pylori Eradication Therapy for Thrombocytopenia after Surgery for Abdominal Aortic Aneurysm with Disseminated Intravascular Coagulation.

Authors:  Takashi Ando; Daichi Akiyama; Hiroshi Okada; Kazuma Date; Hiroshi Furukawa; Makoto Takeda
Journal:  Ann Vasc Dis       Date:  2016-11-23

Review 3.  Natural products and food components with anti-Helicobacter pylori activities.

Authors:  Hiroaki Takeuchi; Vu Thu Trang; Norihito Morimoto; Yoshie Nishida; Yoshihisa Matsumura; Tetsuro Sugiura
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Poor platelet Count Response to Helicobacter Pylori Eradication in Patients with Severe Idiopathic Thrombocytopenic Purpura.

Authors:  Mehrdad Payandeh; Dariyush Raeisi; Nasrollah Sohrabi; Mohammad Erfan Zare; Atefeh Nasir Kansestani; Nazanin Keshavarz; Samira Gholami; Amir Hossein Hashemian
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

Review 5.  Helicobacter pylori Infection and Chronic Immune Thrombocytopenia.

Authors:  Hiroaki Takeuchi; Aoi Okamoto
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.